MONETA GROUP INVESTMENT ADVISORS LLC
Position in CATX — Perspective Therapeutics, Inc.
CIK 1120927
ST LOUIS, MO
Position in CATX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$98,858
+$33,664 QoQ
Shares Held
23,707
0.0% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CATX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026MONETA GROUP INVESTMENT ADVISORS LLC holds $11,029,250 across 8 Medical Devices names. CATX ranks #8 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
45,692 | $4,691,197 | |
| 2 | SYK |
Stryker Corp
|
6,218 | $2,043,172 | |
| 3 | BSX |
Boston Scientific Corp
|
22,180 | $1,391,795 | |
| 4 | EW |
Edwards Lifesciences Corp
|
11,173 | $894,733 | |
| 5 | MDT |
Medtronic plc
|
9,902 | $858,008 | |
| 6 | PEN |
Penumbra Inc
|
2,466 | $809,760 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
3,396 | $241,727 | |
| 8 | CATX |
Perspective Therapeutics, Inc.
This page
|
23,707 | $98,858 |
All Filings in CATX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $98,858 | 23,707 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $65,194 | 23,707 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $81,315 | 23,707 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $81,552 | 23,707 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $50,495 | 23,707 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $75,625 | 23,707 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $316,488 | 23,707 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $236,358 | 23,707 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||